tiprankstipranks
Trending News
More News >
Abbisko Cayman Limited (HK:2256)
:2256
Hong Kong Market
Advertisement

Abbisko Cayman Limited (2256) Similar Stocks

Compare
6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Abbisko Cayman Limited
HK$16.66
HK$11.33B
59.52
460.54%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$10.98
HK$10.70B
58.53
304.74%
0 Buy
0 Hold
0 Sell
Hold
Ascletis Pharma, Inc.
HK$13.84
HK$13.42B
1675.95%
1 Buy
1 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.39
HK$10.36B
427.24
1045.30%
1 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$10.21
HK$14.72B
691.24%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$15.60
HK$9.71B
100.97
80.35%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2256
Abbisko Cayman Limited
16.76
13.74
454.97%
HK:9966
Alphamab Oncology
10.24
7.71
304.74%
HK:1672
Ascletis Pharma, Inc.
14.03
13.24
1675.95%
HK:2142
HBM Holdings Ltd.
13.40
12.23
1045.30%
HK:2616
CStone Pharmaceuticals
10.84
9.47
691.24%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
16.34
7.28
80.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis